Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged >=75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Pharmacodynamics
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2012 Planned End Date changed from 1 Jan 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 04 Nov 2011 New trial record